MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Chorea (also see specific diagnoses, Huntingtons disease, etc): Genetics"

  • MDS Virtual Congress 2020

    Identification of a novel XK mutation in a Chinese patient with McLeod Syndrome

    J. Ma, Y.M Liu (Jinan, China)

    Objective: To present a new McLeod syndrome patient with a novel XKmutation to expand the current knowledge on this disease. Background: McLeod syndrome is an…
  • MDS Virtual Congress 2020

    Aceruloplasminemia Presenting as Huntington’s Disease –Look –Alike with Unique MRI Features

    S. Patil, M. Bhatt, A. Aggarwal (Andheri, Mumbai, India)

    Objective: To report case of generalised chorea due to aceruloplasminemia caused by novel mutation in the CP gene Background: Aceruloplasminemia is a type of Neurodegeneration…
  • MDS Virtual Congress 2020

    Prion disease with 8 octapeptide repeat insertional mutation presenting with HDL1 phenotype

    C. Cooper, D. Hall, B. Fogel, H. Lee, U. Diseases Network (Chicago, IL, USA)

    Objective: To report the clinical and genetic features in a patient with an insertion of 8 extra octapeptide repeats in the prion protein gene (PRNP).…
  • MDS Virtual Congress 2020

    Movement disorders associated with expansions and intermediate repeats in the C9orf72 gene

    C. Estevez-Fraga, F. Magrinelli, A. Latorre, S. Tabrizi, H. Houlden, K. Bhatia (London, United Kingdom)

    Objective: This work sought to investigate the frequency and characteristics of movement disorders (MD) associated with repeat expansions or intermediate repeats in the C9orf72 gene.…
  • MDS Virtual Congress 2020

    Genetic analysis of Huntington’s Disease in a Brazilian Amazonian population

    D. Brito, M. Della Coletta, G. Ferreira, L. Amorim, S. Souza, S. Peixoto, C. Rezende (Manaus, Brazil)

    Objective: Characterize genetically a series of cases of patients with Huntington’s disease and their family members at risk in the city of Manaus, capital of…
  • MDS Virtual Congress 2020

    Huntington’s disease in Egypt; A big challenge for a mysterious disease

    S. El-Jaafary, A. Sabbah, H. Amer (Cairo, Egypt)

    Objective: To identify the challenges of managing Huntington’s disease in Egypt in order to overcome them. Background: Huntington’s disease (HD) is considered a rare disease…
  • MDS Virtual Congress 2020

    Association between the number of CAG repetitions and cognitive performance in Huntington’s disease in patients of the National Institute of Neurology and Neurosurgery “MVS”

    D. Gasca-Saldaña, A. Vega-Rosas, G. Palma-Cordero, O. Castellanos-Maya (CDMX, Mexico)

    Objective: To establish the relationship between the number of CAG repetitions and the total Montreal Cognitive Assessment (MoCA) scores in patients with Huntington disease (HD).…
  • 2019 International Congress

    Whole Exome Sequencing Identifies a Homozygous POLG2 Missense Variant in an adult patient presenting with movement disorders and Mitochondrial DNA Depletion

    P. Dosekova, V. Habalova, M. Skirkova, V. Han, A. Mosejova, Z. Gdovinova, M. Skorvanek, R. Ploski (Kosice, Slovakia)

    Objective: To determine cause of disease in an adult patient with an undiagnosed chronic neurodegenerative disease. Background: POLG2 is a  nuclear gene responsible for mtDNA…
  • 2019 International Congress

    Gene panel testing in movement disorders: an efficient approach highlighting overlaps and heterogeneity

    S. Montaut, C. Tranchant, N. Drouot, G. Rudolf, C. Guissart, J. Tarabeux, T. Stemmelen, A. Velt, C. Fourrage, P. Nitschke, B. Gerard, JL. Mandel, M. Koenig, J. Chelly, M. Anheim (Paris, France)

    Objective: Our study aimed at developing a targeted sequencing approach using a customized panel of genes involved in movement disorders (MDs). Background: MDs are characterized…
  • 2019 International Congress

    NKX2-1-Related Disorder with Cerebral Folate Deficiency

    J. Maclean, Q. Luc, L. Ramos-Platt, S. Saitta, C. Quindipan (Los Angeles, CA, USA)

    Objective: To describe a patient with a de novo NKX2-1 mutation and low CSF 5-methyltetrahydrofolate (5MTHF) who had mild improvement in fine motor control after…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley